SHR-1209

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SHR-1209, covering 2020-07-02 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers [Phase 1]

See pricing